• PDF / 167,209 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 60 Downloads / 201 Views

DOWNLOAD

REPORT

/0863-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 3 Oct 2020 No. 863

1

Recommend Documents

Is LV dysfunction screening in childhood cancer survivors cost effective?

179 0 163KB

Is population genomic screening for breast/ovarian cancer cost effective?

101 72 163KB

MicroRNA-based screening cost effective in diagnosing gastric cancer

153 59 182KB

Modeling the Cost-effectiveness of Esophageal Cancer Screening in China

135 44 2MB

Capecitabine + irinotecan cost effective for colorectal cancer in China

154 88 163KB

Trastuzumab cost effective in early breast cancer

115 43 122KB

Preoperative lymphoscintigraphy cost effective in vulvar cancer

157 31 166KB

Which Strategy Is More Effective for the Treatment of Cardiovascular Disease

147 16 75KB

Effective Complexity: In Which Sense is It Informative?

168 100 627KB

Low-dose CT screening for lung cancer cost effective in smokers

179 11 182KB

HIV screening 3-monthly cost effective in young MSM

158 95 182KB

HSV serology screening cost effective in 3rd trimester of pregnancy

164 75 181KB